The results suggested that RPE could effectively inhibit HBV. The combined anthraquinone chrysophanol 8-O-beta-D-glucoside is the major active compound in RPE and could be a promising candidate for the development of new anti-HBV drugs in the treatment of HBV infection.
| Year | Citations | |
|---|---|---|
1987 | 1.1K | |
1996 | 465 | |
2000 | 368 | |
1991 | 268 | |
1992 | 190 | |
1991 | 186 | |
1990 | 178 | |
1992 | 170 | |
2001 | 160 | |
2003 | 144 |
Page 1
Page 1